A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047

[1]  P. Woster,et al.  Recent advances in the development of polyamine analogues as antitumor agents. , 2009, Journal of medicinal chemistry.

[2]  Nicholas J. Wang,et al.  Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.

[3]  E. Gerner,et al.  Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047. , 2009, Cancer genomics & proteomics.

[4]  David Padua,et al.  Roles of TGFβ in metastasis , 2009, Cell Research.

[5]  James M. Wettenhall,et al.  Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland , 2008, BMC Developmental Biology.

[6]  J. Benítez,et al.  The Molecular Pathology of Hereditary Breast Cancer , 2008, Pathobiology.

[7]  Edward S. Kim,et al.  Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial , 2008, Cancer Prevention Research.

[8]  G. Jönsson,et al.  Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines , 2008, Anti-cancer drugs.

[9]  J. Wang-Rodriguez,et al.  Laminin 5 Expression in Metaplastic Breast Carcinomas , 2008, The American journal of surgical pathology.

[10]  Samuel Leung,et al.  Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.

[11]  L. Marton,et al.  In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells , 2008, Cancer Chemotherapy and Pharmacology.

[12]  A. Mercurio,et al.  Analysis of Integrin β4 Expression in Human Breast Cancer: Association with Basal-like Tumors and Prognostic Significance , 2008, Clinical Cancer Research.

[13]  Jin-cui Ye,et al.  Long Chain Acyl-CoA Synthetase 3-mediated Phosphatidylcholine Synthesis Is Required for Assembly of Very Low Density Lipoproteins in Human Hepatoma Huh7 Cells* , 2008, Journal of Biological Chemistry.

[14]  R. Geha,et al.  WASP-interacting protein (WIP): working in polymerisation and much more. , 2007, Trends in Cell Biology.

[15]  S. Wiseman,et al.  Raft-dependent Endocytosis of Autocrine Motility Factor Is Phosphatidylinositol 3-Kinase-dependent in Breast Carcinoma Cells* , 2007, Journal of Biological Chemistry.

[16]  S. Elledge,et al.  The tumor suppressor CYLD regulates entry into mitosis , 2007, Proceedings of the National Academy of Sciences.

[17]  L. Marton,et al.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases , 2007, Nature Reviews Drug Discovery.

[18]  G. Watkins,et al.  N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer , 2007, Clinical & Experimental Metastasis.

[19]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[20]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[21]  E. Verdin,et al.  Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors , 2006, Molecular Cancer Therapeutics.

[22]  J. Ross,et al.  Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Reinberg,et al.  de FACTo Nucleosome Dynamics* , 2006, Journal of Biological Chemistry.

[24]  Michael Q. Zhang,et al.  Adaptively inferring human transcriptional subnetworks , 2006, Molecular systems biology.

[25]  S. Oredsson,et al.  Differential polyamine analogue effects in four human breast cancer cell lines. , 2006, Toxicology.

[26]  R. Mansel,et al.  Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  S. Tatebe,et al.  Delayed Mechanism for Induction of γ-Glutamylcysteine Synthetase Heavy Subunit mRNA Stability by Oxidative Stress Involving p38 Mitogen-activated Protein Kinase Signaling* , 2005, Journal of Biological Chemistry.

[28]  R. Neve,et al.  A conditional feedback loop regulates Ras activity through EphA2. , 2005, Cancer cell.

[29]  John D. Scott,et al.  CK2 Phosphorylates SSRP1 and Inhibits Its DNA-binding Activity* , 2005, Journal of Biological Chemistry.

[30]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[31]  Y. Kariya,et al.  The basement membrane protein laminin-5 acts as a soluble cell motility factor. , 2004, Experimental cell research.

[32]  B Nebiyou Bekele,et al.  Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[34]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Prados,et al.  Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  D. Brautigan,et al.  Inhibitor-2 Regulates Protein Phosphatase-1 Complexed with NimA-related Kinase to Induce Centrosome Separation* , 2002, The Journal of Biological Chemistry.

[38]  T. Misteli,et al.  A cyclophilin functions in pre‐mRNA splicing , 2002, The EMBO journal.

[39]  B. Gary,et al.  Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  L. Johnson,et al.  Polyamines and cell migration. , 2001, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[41]  Z. Naito,et al.  Expression of Cathepsin B and Cystatin C in Human Breast Cancer , 2001, Surgery Today.

[42]  W. Lim,et al.  Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. , 2000, Science.

[43]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[44]  R. Blantz,et al.  Regulation of intracellular polyamine biosynthesis and transport by NO and cytokines TNF-alpha and IFN-gamma. , 1999, American Journal of Physiology.

[45]  N. Davidson,et al.  Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. , 1999, Endocrine-related cancer.

[46]  L. Marton,et al.  Conformationally restricted analogues of 1N,12N-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines. , 1998, Journal of medicinal chemistry.

[47]  M. Rocchi,et al.  Assignment of the human erythrocyte acylphosphatase gene (ACYP1) to chromosome band 14q24.3 , 1998, Cytogenetic and Genome Research.

[48]  Seymour S. Cohen.  A Guide to the Polyamines , 1998 .

[49]  C. Croce,et al.  Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23. , 1997, Genomics.

[50]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[51]  J. Gray,et al.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.